Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

0.05 mg Versus 0.1 mg Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2011 by Mahidol University.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
Sirilak Suksompong, Mahidol University Identifier:
First received: March 3, 2010
Last updated: September 5, 2011
Last verified: September 2011
This study aims to compare the effect of spinal morphine between the dose 0.05 mg and 0.1 mg on the amount of morphine during the first 24 hours postoperative.

Condition Intervention Phase
Drug: Morphine
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: 0.05 vs. 0.1 Milligram Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy With/Without Anterior and Posterior Vaginoplasty

Resource links provided by NLM:

Further study details as provided by Mahidol University:

Primary Outcome Measures:
  • the amount of 24 hours morphine [ Time Frame: 24 hour ]

Estimated Enrollment: 72
Study Start Date: March 2010
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: spinal morphine 0.05 mg
spinal morphine 0.05 mg plus 0.5% heavy marcaine 3.5 ml
Drug: Morphine
spinal morphine 0.05 mg
Other Name: opioid
Active Comparator: spinal morphine 0.1 mg
spinal morphine 0.1 mg plus 0.5% heavy marcaine 3.5 ml
Drug: Morphine
spinal morphine 0.1 mg plus 0.5% heavy marcaine 3.5 ml
Other Name: Opioid


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Female ASA 1-3
  • Undergoing vaginal hysterectomy with/without anterior and posterior vaginoplasty
  • Can operate PCA device

Exclusion Criteria:

  • History of allergy to the study drugs
  • History of bleeding tendency
  • History of infection at the back
  • Patient refuse to have spinal anesthesia
  • History of CAD or CVD
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01080911

Contact: Sirilak Suksompong, MD 6624113256

Faculty of Medicine, Siriraj Hospital, mahidol University Recruiting
Bangkok, Thailand, 10700
Contact: Sirilak Suksompong, MD    6604113256   
Principal Investigator: Sirilak Suksompong, MD         
Sponsors and Collaborators
Mahidol University
Principal Investigator: Sirilak Suksompong, MD Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital, Mahidol University
  More Information

Responsible Party: Sirilak Suksompong, Associate Professor, Mahidol University Identifier: NCT01080911     History of Changes
Other Study ID Numbers: Si073/2010
Study First Received: March 3, 2010
Last Updated: September 5, 2011

Keywords provided by Mahidol University:
Spinal morphine
Vaginal hysterectomy

Additional relevant MeSH terms:
Analgesics, Opioid
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents processed this record on April 28, 2017